Cleveland Clinic Ventures
Overview
Cleveland Clinic Ventures is the corporate venture capital arm of the Cleveland Clinic, founded in 2000. It focuses on developing, financing, and growing spin-out companies based on intellectual property from Cleveland Clinic innovators, as well as investing in external transformative healthcare technologies. The firm invests in seed, early, and later-stage companies across sectors including medical devices, healthcare information technology, therapeutics, and diagnostics.
Portfolio Companies
11
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Enspire DBS Therapy, Inc. | Jan 2026 | Series B Extension | - |
| MediView XR, Inc. | Oct 2025 | Series A | - |
| Method AI | Aug 2025 | Series A | - |
| Dyania Health | Oct 2024 | Series A | Co-investor |
| XII Medical | Aug 2024 | Series B | - |
Key People
Jihad Kaouk
Chairman, Professor of Surgery, Cleveland Clinic Lerner College of Medicine at Case Western University, Zegarac-Pollock Endowed Chair in Robotic Surgery, Director, Center for Robotics and Image Guided Surgery, Vice Chair, Enterprize Surgical Operations, Institute Vice Chair for Surgical Innovations, Glickman Urologic Institute, Founder and PI, ASPIRE Lab, Staff, Glickman Urologic & Kidney Institute
BUILDER REAL ESTATES AND HOTELS RESORTS AND CLINICS HOSPITALS AND DR MD GINECOLOGIST
CEO
JD Friedland
Executive Director, Ventures
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
